The extension of the credit facility reduces immediate liquidity risk, but investors should monitor the company's ability to secure longer-term financing or improve operating cash flow by July 2026.
Price Chart
Executive Summary
Integrated BioPharma and its subsidiary Manhattan Drug Company received notification from PNC Bank that the expiration date of their line of credit has been extended from April 15, 2026, to July 14, 2026. This provides additional short-term liquidity stability.
Key Facts
- PNC Bank extended the expiration date of the line of credit for Integrated BioPharma and Manhattan Drug Company from April 15, 2026, to July 14, 2026
- The extension was effective April 16, 2026, following notification on April 14, 2026
- The new expiration date may be further extended at PNC's sole discretion
Financial Impact
The extension provides three additional months of credit facility availability, improving short-term liquidity flexibility
Risk Factors
- The extension is temporary and does not resolve longer-term liquidity needs beyond July 2026
- PNC retains sole discretion to further extend the facility, creating uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-012368 |
| Document: 0001437749-26-012368-index-headers.html | 0001437749-26-012368 |
| Document: 0001437749-26-012368-index.html | 0001437749-26-012368 |
| Document: 0001437749-26-012368.txt | 0001437749-26-012368 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $0.1700 $0.1800 | ▼ −5.88% | ▼ −5.91% | $0.1700 (−0.00%) |
Aug 20, 2026 9w ago | 8-K | $0.1800 $0.1700 | ▼ −5.56% | ▼ −5.56% | $0.1700 (−5.56%) |
Jul 2, 2026 16w ago | 8-K | $0.1800 $0.1600 | ▼ −11.11% | ▼ −10.70% | $0.1700 (−5.56%) |
May 8, 2026 24w ago | 8-K | $0.2500 $0.1800 | ▲ +28.00% | ▲ +27.70% | $0.1700 (+32.00%) |
Apr 15, 2026 27w ago | 8-K | $0.2800 $0.2500 | ▼ −10.71% | ▼ −16.76% | $0.1700 (−39.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers